Biotechnology company Pharmology Global Co., Ltd. held the “Skin Innovation Forum” on the 24th of last month and introduced “MINEXIN,” the core functional ingredient of its brand PHARMOLOGY, along with its new product “MINEXIN NEEDLIX,” which incorporates the ingredient.

Held in Seoul, the forum was attended by approximately 100 invited guests from Korea and abroad, including skin care medical professionals and representatives from the biotechnology and beauty industries, who shared the latest research trends and directions for technological development in skin science.

MINEXIN, introduced at the forum, is a “mineral fermented complex metabolite” developed by applying a patented strain to purely isolated natural minerals. Its particles are extremely fine, allowing it to reach deep layers of the skin, and it is characterized by its ability to support the rapid recovery of damaged skin. It is regarded as a material that presents new possibilities in the field of skin regeneration by overcoming the delivery limitations of existing functional ingredients.

In addition, the forum also unveiled “MINEXIN NEEDLIX,” a new product that combines MINEXIN with a microneedle matrix. According to the company, the product contains 45% white spicules with an average length of 150 micrometers, totaling 446,000 ppm, and is designed to maximize the delivery efficiency of active ingredients while minimizing spicule irritation.

MINEXIN NEEDLIX is designed to combine the penetrating power of spicules with the soothing and regenerative functions of MINEXIN, helping to overcome the limitations of existing spicule products while adding new benefits. Another key strength is that it can be expected to improve overall skin texture, tone, and elasticity without the need for separate equipment.

The product’s mechanism of action was also disclosed in detail. MINEXIN NEEDLIX strengthens the skin regeneration environment through a four step process: forming absorption channels through its microneedle structure, activating cellular energy metabolism, enabling sustained release of active ingredients through a porous matrix, and restoring the skin’s natural regeneration cycle.

A Pharmology Global official said, “Through this forum, we were able to officially introduce MINEXIN, our independently developed new material applied to the Pharmology brand, along with our technology based products, to domestic and international participants,” adding, “We plan to further strengthen research collaboration in the global market expansion and professional aesthetic fields.”